Apellis Pharmaceuticals, Inc. (APLS)

20.96 -0.68 (-3.14%) USD  |  NASDAQ  |  Feb 27, 16:00
20.80 -0.16 (-0.76%) After-Hours: 20:00
More

Apellis Pharmaceuticals Total Equity Including Minority Interest (Quarterly)

Total Equity Including Minority Interest (Quarterly) Chart

View Total Equity Including Minority Interest (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Equity Including Minority Interest (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years

View Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Equity Including Minority Interest (Quarterly) Benchmarks

View Total Equity Including Minority Interest (Quarterly) Benchmarks
Start Trial
Ultragenyx Pharmaceutical, Inc. Upgrade
Amneal Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade